
Fibromyal-SP Tablets by Krisa Healthcare contain Aceclofenac, Paracetamol and Serratiopeptidase, a combination prescribed for the short-term management of pain and inflammation associated with selected musculoskeletal conditions.
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that helps reduce pain and inflammation by inhibiting prostaglandin production. Paracetamol acts as an analgesic and antipyretic, providing additional pain relief and helping reduce fever.
Serratiopeptidase is a proteolytic enzyme included in formulations intended to support the management of inflammation and swelling, although evidence for its additional clinical effectiveness remains limited.
Fibromyal-SP Tablets may be prescribed for muscle pain, joint discomfort, sprains, strains, dental pain and certain postoperative conditions when this combination is considered appropriate.
The medicine should be taken strictly according to a registered medical practitioner's prescription. Dosage and treatment duration depend on the patient's medical condition and response to treatment.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Krisa Healthcare is an Indian pharmaceutical contract and third-party manufacturing company based in Baddi, Himachal Pradesh.
Key Details
• Location: Plot No. 6, Apparel Park Cum Industrial Area, Katha, Baddi – 173205, Himachal Pradesh, India.
• Established: 2017
• Certifications: WHO-GMP, GMP, and ISO compliant.
• Core Services: Third-party manufacturing, contract manufacturing, private labeling, custom formulations, and PCD Pharma Franchise opportunities.
• Product Portfolio: Over 800 formulations spanning tablets, capsules, softgels, dry syrups, liquid orals, injections, oils, creams, powders, and critical care/cardiac-diabetic ranges.
• Contact:
• Phone: +91 83518-23187 / +91 88942-93172
• Email: krisa.healthcare@gmail.com
• Official Website: Krisa Healthcare.